89bio, Inc. logo ETNB - 89bio, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 6
SELL 0
STRONG
SELL
0
| PRICE TARGET: $14.50 DETAILS
HIGH: $14.50
LOW: $14.50
MEDIAN: $14.50
CONSENSUS: $14.50
DOWNSIDE: 2.29%
Market Cap: 2.20B
Volume: 38,511,212
Avg Volume: 5,393,196
52 Week Range: 4.16-15.06
Sector: Healthcare
Industry: Biotechnology
Beta: 1.26
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 93
IPO Date: 2019-11-11
EPS (TTM): -3.51
P/E Ratio: -2.23
Revenue (TTM): N/A
Total Assets: 478.69M
Total Debt: 37.55M
Cash & Equiv: 126.06M
Rev Growth (5Y): N/A
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -84.0%
Debt/Equity: 0.09

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-06 $-1.39 $-0.50 -178.0%
2025-08-07 $-0.71 $-0.49 -44.9%
2025-05-01 $-0.49 $-0.50 +2.0%
2025-02-27 $-1.02 $-0.60 -70.0% $21000
2024-11-07 $-1.39 $-0.64 -117.2% $750000
2024-08-05 $-0.48 $-0.57 +15.8% $540000
2024-05-09 $-0.54 $-0.46 -17.4%
2024-02-29 $-0.50 $-0.49 -2.0% $234000

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018
Revenue 0 0 0 0 0 0 0
Net Income (367.08M) (142.19M) (102.03M) (90.12M) (49.50M) (57.42M) (16.18M)
EPS -3.51 -2.00 -2.93 -4.48 -3.08 -5.40 -3.53
Total Assets 478.69M 596.27M 196.82M 162.42M 211.07M 95.55M 11.37M
Total Debt 37.55M 27.11M 20.55M 19.40M 0 0 24.74M
Cash & Equivalents 126.06M 316.16M 55.26M 52.43M 98.18M 93.36M 11.23M
Operating Cash Flow (367.82M) (129.19M) (81.09M) (76.78M) (46.24M) (25.46M) (12.47M)
Free Cash Flow (367.84M) (129.19M) (81.10M) (76.84M) (46.37M) (25.60M) (12.51M)
FCF per Share -3.51 -1.82 -2.33 -3.82 -2.88 -2.41 -2.73
Book Value 400.79M 536.31M 151.83M 125.96M 202.96M 89.94M (16.06M)
Cash & ST Investments 439.95M 578.87M 188.16M 150.75M 204.65M 93.36M 11.23M
ROC Equity -0.92 -0.27 -0.67 -0.72 -0.24 -0.64 N/A